Thrombosis
From the Journals
Merits of short DAPT, de-escalation in ACS challenge guidelines
Results from the meta-analysis should put the alternative strategies on par with each other or even dethrone standard DAPT in current guidelines,...
From the Journals
‘Substantial’ CVD risks, burden up to a year after COVID-19
Governments and health systems need to be prepared to deal with the likely significant contribution of the pandemic to a rising burden of...
From the Journals
Seniors face higher risk of other medical conditions after COVID-19
The risk of a new condition being triggered by COVID is more than twice as high in seniors, compared with younger patients, new research suggests...
From the Journals
Ischemic stroke rates higher in young women than young men
Young women may be at a higher risk of ischemic stroke than young men, representing a “significant departure from our current scientific...
Feature
CVS Caremark formulary change freezes out apixaban
The decision doesn’t affect patients on a Medicare or Medicaid plan but hits those taking the popular anticoagulant who have select commercial...
Feature
A high-risk medical device didn’t meet federal standards. The government paid millions for more
For years after federal inspectors found serious problems with the HeartWare heart pump, agencies like the Department of Veterans Affairs and...
From the Journals
Who benefits most from device PFO closure after a stroke?
Younger patients with high-risk physiological features but no vascular risk factors may benefit most from patent foramen ovale closure with a...
News from the FDA/CDC
CDC panel backs mRNA COVID vaccines over J&J because of clot risk
The risk of dying from TTS after a Johnson & Johnson shot is extremely rare.
From the Journals
D-dimer thresholds rule out PE in meta-analysis
Data from a large review support use of D-dimer levels to diagnose PE without imaging.
Guidelines
ACC, AHA issue new coronary revascularization guideline
The clinical practice guideline calls for greater equity in patient care and tackles the timely issues of revascularization in stable ischemic...
From the Journals
Apixaban outmatches rivaroxaban for VTE in study
These real-world findings may guide selection of initial anticoagulant therapy, according to authors of the paper.